1,881
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Assessing the clinical utility of multi-omics data for predicting serous ovarian cancer prognosis

, , , &
Article: 2171778 | Received 26 Aug 2022, Accepted 19 Jan 2023, Published online: 21 Feb 2023

References

  • Ali, F.T., et al., 2022. Sensitivity and specificity of microRNA-204, CA125, and CA199 as biomarkers for diagnosis of ovarian cancer. PLOS One., 3, e0272308.
  • Arora, T. and Manidhar Reddy Lekkala, M., 2022. Ovarian cancer. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing.
  • Balkwill, F., 2004. Cancer and the chemokine network. Nature Reviews Cancer, 4 (7), 540–550.
  • Bizzarri, N., et al., 2021. Is there any therapeutic role of pelvic and para-aortic lymphadenectomy in apparent early stage epithelial ovarian cancer? Gynecologic Oncology, 160 (1), 56–63.
  • Chaudhary, K., et al., 2018. Deep learning based multi-omics integration robustly predicts survival in liver cancer. Clinical Cancer Research, 24 (6), 1248–1259.
  • Chi, S.Q., et al., 2019. Semi-supervised learning to improve generalizability of risk prediction models. Journal of Biomedical Informatics, 92, 103117.
  • Eriksson, L., et al., 2004. Using chemometrics for navigating in the large data sets of genomics, proteomics, and metabonomics (gpm). Analytical and Bioanalytical Chemistry, 380 (3), 419–429.
  • Fagotti, A., et al., 2020. Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850). International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society, 30 (11), 1657–1664.
  • Feng, L.Y., et al., 2021. Abnormal methylation characteristics predict chemoresistance and poor prognosis in advanced high-grade serous ovarian cancer. Clinical Epigenetics, 13 (1), 141.
  • Ge, L., et al., 2022. Plasma circRNA microarray profiling identifies novel circRNA biomarkers for the diagnosis of ovarian cancer. Journal of Ovarian Research, 15 (1), 58.
  • Gerstung, M., et al., 2015. Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes. Nature Communications, 6, 5901.
  • Guo, Y., Lu, Y.L. and Jin, H.C., 2020. Appraising the role of circulating concentrations of micro-nutrients in epithelial ovarian cancer risk: a Mendelian randomization analysis. Scientific Reports, 10 (1), 7356.
  • Harrell, F.E., JR, et al., 1996. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Statistics in Medicine, 15 (4), 361–387.
  • Kim, Y.J., et al., 2022. RGB channel superposition algorithm with acetowhite mask images in a cervical cancer classification deep learning model. Sensors, 22 (9), 3564.
  • Krzywinski, M., et al., 2009. Circos: an information aesthetic for comparative genomics. Genome Research, 19 (9), 1639–1645.
  • Laganà, A.S., et al., 2015. Cytogenetic analysis of epithelial ovarian cancer’s stem cells: an overview on new diagnostic and therapeutic perspectives. European Journal of Gynaecological Oncology, 36 (5), 495–505.
  • Mezzanzanica, D., et al., 2008. Subcellular localization of activated leukocyte cell adhesion molecule is a molecular predictor of survival in ovarian carcinoma patients. Clinical Cancer Research, 14 (6), 1726–1733.
  • Mi, H., et al., 2013. Large-scale gene function analysis with the PANTHER classification system. Nature Protocols, 8 (8), 1551–1566.
  • Neul, C., et al., 2016. Impact of membrane drug transporters on resistance to small-molecule tyrosine kinase inhibitors. Trends in Pharmacological Sciences, 37 (11), 904–932.
  • Ogrinc, G., et al., 2019. SQUIRE-EDU (Standards for QUality Improvement Reporting Excellence in Education): publication guidelines for educational improvement. Academic Medicine, 94 (10), 1461–1470.
  • Schadendorf, D., et al., 1995. Membrane transport proteins associated with drug resistance expressed in human melanoma. The American Journal of Pathology, 147 (6), 1545–1552.
  • Schmidhuber, J., 2015. Deep learning in neural networks: an overview. Neural Networks, 61, 85–117.
  • Silver, D., et al., 2016. Mastering the game of Go with deep neural networks and tree search. Nature, 529 (7587), 484–489.
  • Spizzo, G., et al., 2006. Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer. Gynecologic Oncology, 103 (2), 483–488.
  • Sung, H., et al., 2021. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71 (3), 209–249.
  • Vitale, S.G., et al., 2019. Management of endometrial, ovarian and cervical cancer in the elderly: current approach to a challenging condition. Archives of Gynecology and Obstetrics, 299 (2), 299–315.
  • Yuan, Y., et al., 2014. Assessing the clinical utility of cancer genomic and proteomic data across tumor types. Nature Biotechnology, 32 (7), 644–652.
  • Zhang, J., et al., 2011. International Cancer Genome Consortium Data Portal – a one-stop shop for cancer genomics data. Database: The Journal of Biological Databases and Curation, 2011, bar026.,
  • Zhang, M., et al., 2021. Roles of CA125 in diagnosis, prediction, and oncogenesis of ovarian cancer. Biochimica et Biophysica Acta Reviews on Cancer, 1875 (2), 188503.